Skip to main content
Chemours Co (CC)
Chemicals Basic Materials
Stock AI

Chemours Co. Q1 2025 Report: Navigating Challenges Amid Strategic Changes

Last updated: May 06, 2025
Taurigo

Chemours Co., a leading player in the global performance chemicals sector, has released its Q1 2025 financial report, reflecting a complex blend of operational challenges and strategic shifts. The company, which specializes in industrial and specialty chemical products, reported a net sales figure of $1.4 billion, maintaining stability compared to the same quarter in 2024, despite facing considerable headwinds.

1. Key Financial Metrics

Income Statement Overview

In the first quarter of 2025, Chemours reported a net income of -$4 million, a stark contrast to the $52 million profit from the same period in the previous year. The decline was attributed to several factors, including increased costs and restructuring charges related to the exit from the Surface Protection Solutions (SPS) Capstone business.

Income Statement of Chemours Co
Apr 2024 May 2025
Net Income
-331M30M
Net Income to Non-controlling Interest
-1M0
Profit
-330M30M
Net Income Continuing
-330M88M
Income Tax Expense
-94M30M
Pretax Income
-424M118M
Non-operating Income
-135M70M
Operating Income
-335M282M
Revenue
5.84B5.8B
Costs and Expenses
6.17B5.51B
Cost of Revenue
4.61B4.69B
Operating Expenses
1.55B819M
Impairment Expense
056M
Research & Development
110M108M
Selling, General & Administrative
1.30B566M
Other Operating Expenses
141M89M

Balance Sheet Insights

Chemours’ balance sheet as of March 31, 2025, shows total assets of $7.39 billion, a decrease from $7.97 billion in 2024. Notably, current assets dropped from $3.59 billion to $2.93 billion, highlighting the impact of operational adjustments and restructuring efforts.

Balance Sheet of Chemours Co
Apr 2024 May 2025
Total Assets
7.97B7.39B
Total Current Assets
3.59B2.93B
Cash and Equivalents
746M464M
Net Inventories
1.39B1.55B
Restricted Cash and Investments
607M0
Prepaid Expenses
61M61M
Total Non-current Assets
4.38B4.46B
Intangible Assets
105M48M
Long-term Investments
165M164M
Net PP&E
3.20B3.13B
Lease Assets
252M286M
Other Non-current Assets
650M832M
Total Liabilities and Equity
7.97B7.39B
Total Liabilities
7.22B6.81B
Total Current Liabilities
2.23B1.67B
Accounts Payable and Accrued Liabilities
2.06B1.53B
Current Debt
41M43M
Other Current Liabilities
129M100M
Total Non-current Liabilities
4.99B5.14B
Long-term Debt
3.96B4.06B
Non-current Deferred Tax Liabilities
44M28M
Other Non-current Liabilities
981M1.04B
Total Equity and Non-controlling Interests
754M580M
Total Equity
752M579M
Non-controlling Interests
2M1M

Cash Flow Analysis

The cash flow statement reflects a net change in cash of -$249 million for the quarter, a notable improvement over the -$454 million seen in Q1 2024. This change was influenced by cash generated from operating activities, although it still indicates ongoing liquidity challenges.

Cash Flow Statement of Chemours Co
Apr 2024 May 2025
Net Change in Cash
332M-839M
Effect of Exchange Rate Changes
-11M-7M
Net Cash from Operating Activities
385M-455M
Operating Profit
-330M30M
Adjustment to Operating Profit
715M-485M
Net Cash from Investing Activities
-233M-338M
Productive Assets
235M342M
Other Investing Activities
2M4M
Net Cash from Financing Activities
191M-39M
Debt
357M99M
Dividends
149M148M
Equity Issuance/Repurchase
-37M8M
Other Financing Activities
20M2M

2. Business Segment Performance

Thermal & Specialized Solutions

The Thermal & Specialized Solutions segment delivered net sales of $466 million, a 3% increase bolstered by a 10% rise in volume, although this was partially offset by a 6% decrease in pricing. Despite the growth in sales, Adjusted EBITDA dipped by 6% to $141 million due to price pressure.

Titanium Technologies

In the Titanium Technologies segment, net sales reached $597 million, a modest 1% increase driven by volume growth. However, operational challenges, particularly related to adverse weather conditions, caused Adjusted EBITDA to decline by 28% to $50 million.

Advanced Performance Materials

The Advanced Performance Materials segment reported net sales of $294 million, down 3% from the previous year. This decline was largely attributed to a decrease in volume and unfavorable currency movements, yet the segment managed to increase Adjusted EBITDA by 7% to $32 million, thanks to lower operational costs.

3. Recent Developments and Strategic Initiatives

Exit from Surface Protection Solutions

Chemours' decision to exit its SPS Capstone business in January 2025 was driven by a combination of regulatory changes and a downturn in demand. The company incurred $27 million in charges related to this restructuring, marking a significant shift in its operational strategy.

Credit Agreement Amendment

In a bid to bolster its financial flexibility, Chemours amended its credit agreement in May 2025, increasing revolving commitments to $1 billion. This proactive measure aims to enhance liquidity as the company navigates through its restructuring phase.

Partnerships and Innovation

Chemours has been active in forming strategic alliances, such as the recent manufacturing agreement with Navin Fluorine International, Ltd., aimed at producing innovative cooling fluids. This aligns with Chemours’ Pathway to Thrive strategy, emphasizing sustainability and innovation in its product offerings.

4. Environmental Commitments

As part of its corporate responsibility, Chemours is committed to addressing environmental concerns associated with its operations. The company reported environmental remediation liabilities totaling $567 million, underscoring the ongoing challenges it faces in compliance with environmental regulations.

5. Conclusion

Chemours Co. continues to adapt to a rapidly evolving market landscape, marked by strategic exits and new partnerships. While the financial results for Q1 2025 reflect significant challenges, particularly in profitability and cash flow, the company's focus on innovation and environmental stewardship positions it for potential recovery and growth in the future. The path forward will depend on Chemours' ability to effectively manage its restructuring efforts while capitalizing on opportunities within its core business segments.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.